MedPath

Investigational Multi-purpose Contact Lens Care Solution.

Not Applicable
Completed
Conditions
Contact Lens Wear
Interventions
Device: Vistakon Investigational Multi-Purpose Solution I
Device: ReNu MultiPlus Multi-Purpose Solution
Registration Number
NCT01055613
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
312
Inclusion Criteria
  • must be an adapted contact lens wearer
  • best corrected distance visual acuity must be 20/25 or better in each eye
  • must be wearing their habitual lenses on a daily wear basis
  • must be willing to refrain from swimming during the study
Exclusion Criteria
  • any systemic diseases that may interfere with contact lens wear
  • any clinically significant ocular disease
  • any ocular infection
  • use of certain medications
  • any grade 2 or greater slit lamp findings
  • any know sensitivity to marketed contact lens care solutions
  • currently pregnant or lactating
  • monovision corrected

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental multi-purpose solutionVistakon Investigational Multi-Purpose Solution IMulti-purpose contact lens care solution.
ReNu MultiPlus Multi-Purpose SolutionReNu MultiPlus Multi-Purpose SolutionMulti-purpose contact lens care solution.
Primary Outcome Measures
NameTimeMethod
Slit Lamp Findings3 months

Each subjects' eye was examined using a bio-microscope. Slit lamp findings were graded with a 5-point scale (i.e. Grade 0= None, Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). The number of eyes with Grade 3 or higher for each lens was reported for each assessment.

Distance Visual Acuity (LogMAR)Up to 3 Months

Distance visual acuity was collected at the 1-, 2-, 3-week and 1- and 3- month follow-up evaluations. The average LogMAR across all visits for each lens type was reported.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath